Company & Sponsor Intelligence
Sherief Abd-Elsalam
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting3
Completed0
Countries1
Therapeutic footprint
adhdautismepilepsy
Indexed studies
NCT04216186Role of Coenzyme Q in ADHD in Children
adhd · EgyptPHASE3
adhd · EgyptPHASE3
NCT04144439Effect of GABA on ADHD and Seizures in Children With Epilepsy.
epilepsy · EgyptPHASE4
epilepsy · EgyptPHASE4
NCT04766177Role of Bumetanide in Treatment of Autism
autism · EgyptPHASE3
autism · EgyptPHASE3
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →